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Abstract: Malate Dehydrogenase (MDH) and
Lactate Dehydrogenase (LDH) activities were
demonstrated in the mitochondrial and
cytosolic fractions of an intestinal cestode,
Taenia saginata, and then the in vitro effects
of three anthelminthics, albendazole,
niclosamide, and piperazine on these
enzymes were investigated. The Vmax and
Km values of MDH were found to be 3.00
µmol (min mg protein)–1 and 0.0166 mM
respectively. In vitro addition of albendazole
and niclosamide increased the Vmax value of
MDH, whereas it decreased Km value of MDH
(p<0.05). The Vmax and Km values of LDH
were found to be 0.028 µmol (min mg
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Introduction
Infections caused by helminths represent a major
threat to the health of milions of people throughout the
world. Many species of parasitic helminths are responsible
for disease in humans. The range of anthelminthic drugs
currently available provides a powerful armamentarium
against most human helminthic infections. Niclosamide is
generally regarded as a very effective agent for treating
most infections by cestodes in animals and man (1). The
anthelminthic mechanism of niclosamide is not completely
understood (2). Albendazole is a broad–spectrum
anthelminthic of the benzimidazole carbamate class,
which is effective against larval and adult stages of
cestodes and trematodes (3). Some workers have shown
its effect by interaction with micro tubules of parasites;
however, it has been suggested that anthelminthics work
in different ways in different parasites (4). Piperazine, a
heterocyclic organic base, has been widely used as an
anthelminthic, particularly against Ascaris lumbricoides
and Enterobius vermicularis (3). The anthelminthic
activity of piperazine is reported to be dependent on its
anticholinergic action (5).

protein)–1 and 0.055 mM respectively.
Albendazole and niclosamide solutions
increased the Vmax value of LDH (P<0.05).
Km value of LDH was reduced albendazole
and niclosamide solutions (P<0.05).
Piperazine affected neither MDH nor LDH
activites. These results suggest that the
activity of MDH and LDH in T. saginata are
activated and the carbohydrate metabolism
of this parasite is changed by albendazole and
niclosamide.
Key Words: Malate Dehydrogenase, Lactate
Taenia
saginata,
Dehydrogenase,
albendazole, niclosamide, piperazine.

Taeniidis are large tapeworms, common throughout
the world. Two species, Taenia saginata and T. solium,
are common parasites of man. In Turkey, T. saginata has
become widespread, especially in south–east Anatolia,
east Anatolia and in Sivas (6, 7). Little information is
available on the nutrition and metabolism of T. saginata
with regard to that of other cestodes (8). Glycogen is the
main energy reserve and glycogen and glucose are
degraded
to
phosphoenolpyruvate
via
the
Emden–Meyerhof glycolytic pathway. There are two
major pathways for the subsequent catabolism of
phosphoenolpyruvate. First, phosphoenolpyruvate is
reduced to malate, which enters the mitochondria.
Second, it is transformed to pyruvate which is reduced to
lactate by lactate dehydrogenase (9). Similar to that of
vertebrates, the inner membrane of the mitochnodrion in
helminths is impermeable to NADH, which is transferred
from the cytoplasm to the mitochondrion in mammalian
mitochondria via the malate/aspartate shuttle system.
Malate dehydrogenase is the rate–limiting enzyme in the
phosphoenolpyruvate metabolism and of this shuttle
system. It is not known if this shuttle system is operative
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in some helminths (9) The present studies were designed
to delineate the kinetic properties of MDH and LDH in T.
saginata, and to determine the effects of niclosamide,
albendazole and piperazine on the activities of these
enzymes.
Material and Methods
Materials
KH2PO4, K2HPO4, sucrose, EDTA Coomassie Brilliant
Blue G250 and perchloric acid were obtained from Merck.
Bovine serum albumin (BSA), pyruvate, oxaloacetate, and
NADH were purchased from Sigma. Niclosamide,
piperazine and albendazole were a gift from Atabay Drug
Factory (İstanbul). Andazol was purchased from
Biofarma. Albendazole did not dissolve in the solvents
tested, and was therefore tested using an andazol
suspension.
Methods
Proglottids of T. saginata expelled spontaneously
were collected from patients with taeniasis. Proglottids of
T. saginata were thoroughly rinsed in Ringer’s solution
and used within 1–2 h after removal from the host.
Proglottids were weighed wet. Each gram of proglottid
was homogenised in 10 mL of 0.24 M sucrose buffer
containing 0.005 M EDTA (pH 7.4) solutions with a
Braun Potter Elvehjen homogeniser with telfon piston at
0°C. The homogenate was centrifuged at 110 g for 10
min using a Beckman L5–70 centrifuge. This and further
processes were performed at 4°C. The sediment was
removed and the supernatant was then centrifuged at
6750 g for 30 min. The supernatant was collected and
used as a source of LDH. The mitochondrial pellet was
suspended in 5 mL mitochondrial media (10). The
suspension was sonicated in an ice bath for 5–6 sec and
used as a source of MDH. Protein concentrations of these
mitochondrial and cytosolic fractions were determined by
the method of Bradford using BSA as standard (11).
LDH activity was measured as the rate of oxidation of
NADH at 340 nm and 25°C in a recording Shimadzu
model UV–VIS spectrophotometer (12). In all cases, the
volume of the reaction mixture was 3 mL, the light path
1 cm and the value of molar extinction coefficient ε340
2
–1
nm=6.22 cm µmol . The composition of the reaction
mixture was 94 mM phosphate buffer (pH 7.5), 0.038
mM pyruvate, 0.2 mM NADH and 50 µL cytoplasmic
fraction (corresponding to 12.8 mg mL–1 protein).
MDH activity was measured as the rate of oxidation of
NADH at 340 nm and 25°C in a recording Sichmatsu
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model UV–VIS spectrophotometer (13). In all cases, the
volume of the reaction mixture was 3 mL, the light path
1 cm and the value of molar extinction coefficient
ε340 nm=6.22 cm2 µmol–1. The composition of the reaction
mixture was 94 mM phosphate buffer (pH 7.5), 0.25
mM oxaloacetate, 0.2 mM NADH and 50 µL of
mitochondrial medium (corresponding to 0.44 mg mL–1
protein).
Michaelis–Menten kinetic parameters Vmax
(maximum of apparent initial enzyme velocity) and Km
(substrate affinity constant) values were determined by
assaying the enzymes at different substrate
concentrations and constructing a Lineweaver–Burk
double reciprocal plot of substrate concentrations and
enzyme velocity (14).
The method for determination of the effects of
albendazole, niclosamide and piperazine on enzyme
activity was similar to that for enzyme activity described
above, except that different concentrations of
anthelminthics (0.158 mM, 0.633 mM, 1.266 mM
albendazole, 0.032 mM, 0.063 mM, 0.127 mM
niclosamide, 3.0 mM, 12.0 mM, 22.0 mM piperazine)
were used, and measurements were made following
incubation at 25°C for 10 min. This period was chosen
because greater incubation times did not give greater
activation percentages. Data were analysed statistically
with the Mann–Whitney u–test and correlatin analyses
(15).
Results
Initial rates of NADH oxidation were obtained for
various levels of oxaloacetate and pyruvate solutions.
These data were plotted according to the method of
Lineweaver –Burk, and Vmax and Km values were
determined. The Vmax and Km values for MDH were
3.00 µmol (min mg protein)–1 and 0.0166 mM,
respectively. The Vmax and Km valueus for LDH were
0.028 µmol (min mg protein)–1 and 0.055 mM,
respectively.
As the results of the interaction of albendazole and
niclosamide with MDH Lineweaver –Burk plots are shown
in Figure 1 and Figure 2, respectively. Lineweaver –Burk
plots showing the results of experiments investigating the
effects of albendazole and niclosamide on LDH are shown
in Figure 3 and Figure 4, respectively. Vmax and Km
values for these enzymes are shown in Table 1 and
Table 2.
At all concentrations tested, piperazine did not affect
MDH or LDH activity.
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Figure 1.

Lineweaver–Burk plot
for MDH in Taenia
saginata with varying
amounts of albendazole.
––l––:
Enzyme;
––u––: 0.158 mM
albendazole; ––n––:
0.633 mM albendazole;
––s––: 1.266 mM
albendazole.

Figure 2.

Lineweaver–Burk plot
for MDH in Taenia
saginata with varying
amounts of niclosamide.
––l––:
Enzyme;
––u––: 0.032 mM
niclosamide; ––n––:
0.063 mM niclosamide;
––s––: 0.127 mM
niclosamide.
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Figure 3.

Lineweaver–Burk plot
for
LDH in
Taenia
saginata with varying
amounts of albendazole.
––l––:
Enzyme;
––u––: 0.158 mM
albendazole; ––n––:
0.633 mM albendazole;
––s––: 1.266 mM
albendazole.

Figure 4.

Lineweaver–Burk plot
for
LDH in
Taenia
saginata with varying
amounts of niclosamide.
––l––:
Enzyme;
––u––: 0.032 mM
niclosamide; ––n––:
0.063 mM niclosamide;
––s––: 0.127 mM
niclosamide.
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Table 1.

Effects of albendazole on MDH and LDH in T. saginata.
MDH*

Concentrations of
Albendazole/mM

0.000
0.158
0.633
1.266
*

Vmax/µmol
(min mg protein)–1
3.00 ±
3.30 ±
3.46 ±
5.00 ±

LDH*
Km/mM
(for oxaloacetate)

0.01
0.02
0.01
0.03

0.0166
0.0138
0.0095
0.0066

±
±
±
±

0.0003
0.0003
0.0002
0.0001

Vmax/µmol
(min mg protein)–1
0.028
0.030
0.042
0.050

±
±
±
±

0.001
0.001
0.002
0.002

0.055
0.040
0.027
0.020

±
±
±
±

0.002
0.003
0.003
0.002

values are mean ± Standard error from five sets of experiments.

Table 2.

Effects of niclosamide on MDH and LDH in T. saginata.
MDH*

Concentrations of
Niclosamide/mM

0.000
0.032
0.063
0.127
*

Km/mM
(for pyruvate)

Vmax/µmol
(min mg protein)–1
3.00 ±
3.70 ±
4.60 ±
5.80 ±

0.01
0.03
0.02
0.01

LDH*
Km/mM
(for oxaloacetate)
0.0166
0.0133
0.0120
0.0100

±
±
±
±

0.0003
0.0002
0.0002
0.0002

Vmax/µmol
(min mg protein)–1
0.028
0.030
0.036
0.045

±
±
±
±

0.001
0.001
0.003
0.003

Km/mM
(for pyruvate)
0.055
0.042
0.032
0.022

±
±
±
±

0.002
0.002
0.003
0.001

values are mean ± Standard error from five sets of experiments.

Discussion
Parasitic infections constitute a significant health risk
to humans, particularly in undeveloped and developing
countries. For this reason, the relationships between
parasites and chemotherapeutics are important. In this
study, the effects of niclosamide, albendazole and
piperazine on the activities of MDH and LDH in T.
saginata were investigated.
In the experiments of various investigators, the MDH
activity of parasitic helminths has been investigated.
Zenka et al. found the cytoplasmic MDH activity of Taenia
crassiceps larvae to be 0.1235 µmol (min mg protein)–1
and the mitochondrial MDH activity of the same parasite’s
larvae to be 84 µmol (min mg protein)–1 (16). In another
study by Zenka et al., the Km value of cytoplasmic MDH
of T. crassiceps cysticercus was found to be 7.8 x 10–5 M,
and the Km value of S. mansoni was found to be 4 x 10–5
M (17).
In the present study, Vmax an Km values for MDH
were found to be 3.00 µmol (min mg protein)–1 and
0.0166 mM, respectively.

Tejada et. al., showed that MDH activity in A. suum,
F. hepatica and M. expansa was inhibited by
mebendazole, albendazole and parbendazole (18).
However, it was suggested that anthelminthics work in
different ways in different parasites. In the present study,
there was a significant positive correlation between the
Vmax value for MDH in T. saginata and anthelminthic
concentration (r=0.95 for albendazole and r=0.99 for
niclosamide) and there was a significant negative
correlation between the Km value for MDH in T. Saginata
and anthelminthic concentration (r=–0.97 for
albendazole and r=–0.95 for niclosamide). That is to say,
a significant activation of MDH was observed following
exposure to albendazole and niclosamide adipate
(P<0.05) (Table 1 and Table 2). Piperazine did not affect
MDH activity.
In experiments by various investigators, the LDH
activity of parasitic helminths has been investigated. It has
been found to be 143 nmol (min mg protein)–1 in adult A.
lumbricoides, 353 nmol (min mg protein)–1 in adult H.
diminuta, 1365 nmol (min mg protein)–1 in adult
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Litomosoides carinii and 6.1 nmol (min mg protein)–1 in
adult Ascaridia galli (19). In the present study LDH
activity of T. saginata was investigated. The Vmax and
Km values of this enzyme were 0.028 µmol (min mg
protein)–1 and 0.055 mM, respectively.
In a study by Pampori et al. (20) niclosamide,
praziquantel, and mebendazole were shown to increase
lactate production. Sharma et al. showed that LDH in A.
galli and H. gallinae was not affected by albendazole and
levamisole (4). Statistical evaluation of the present results
reveals a positive correlation between the Vmax value for
LDH in T. saginata and anthelminthic concentration
(r=0.98 for albendazole and r=0.98 for niclosamide),
and a negative correlation was observed between the Km

value for LDH in T. saginata and anthelminthic
concentration (r=–0.92 for albendazole and r=–0.92 for
niclosamide). That is to say, significant activation of LDH
was observed following exposure to albendazole and
niclosamide adipate statistically (P<0.05) (Table 1 and
Table 2).
Sharma et al. (5) showed that the LDH activity of A.
galli and H. gallinae was not affected by piperazine.
Similarly, in the present study, LDH activity in T. saginata
was not affected by piperazine.
According to these results, it was established that
anthelminthics like niclosamide and albendazole affect
LDH and MDH for T. saginata, and hence the
carbohydrate metabolism of this parasite changes.
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